Markus Lusser, President of Abcam (PRNewsfoto/Abcam)
CAMBRIDGE, England, March 18, 2024 /PRNewswire/ — Abcam announced the appointment of Markus Lusser as President.
Markus joined Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio. With extensive experience in the life sciences and medical device industries, Markus aims to enhance Abcam’s innovative solutions for customers.
He previously served in leadership roles at Danaher and Siemens Healthineers, driving growth and innovation. Markus emphasizes building customer-centric cultures and fostering cross-functional teamwork.
His mission as Abcam’s President is to prioritize customer needs, collaboration, and innovation. Markus replaces Alan Hirzel as CEO. Abcam, headquartered in Cambridge, UK, operates globally and serves researchers worldwide with its biological reagents and solutions.
Saudi Arabia weighs price war or stability after UAE exit from OPEC+, with Malaysia’s O&G…
Advancecon Holdings has secured a RM48 million contract for infrastructure work in Johor, signaling strong…
UAE exit from OPEC+ and USD100 oil boost Malaysia’s energy outlook; Dialog and Hibiscus seen…
Malaysia benefits from high oil prices, but faces inflation and logistical risks due to the…
ASEAN manufacturing PMI falls to six-month low as Middle East war drives price pressures, supply…
FBM KLCI advanced on stronger buying momentum despite global market weakness, rising geopolitical tensions and…
This website uses cookies.
